World
What a vote on Grail cancer detection test may mean for the Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.
Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.
Dr. Kai NakamuraChief Science CorrespondentPublished Sep 21, 2026 at 4:31 PM EDT · 1 min read
What a vote on Grail cancer detection test may mean for the Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting. Shares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.